These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 176608

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro.
    Yamashita Y, Kawai M, Hotta K.
    Jpn J Pharmacol; 1976 Jun; 26(3):391-4. PubMed ID: 185445
    [No Abstract] [Full Text] [Related]

  • 3. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
    Schwabe U, Miyake M, Ohga Y, Daly JW.
    Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of 3',5'-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo.
    Nahorski SR, Rogers KJ.
    Neuropharmacology; 1976 Oct; 15(10):609-12. PubMed ID: 186725
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of ethanol on the cyclic AMP system of the dog gastric mucosa.
    Puurunen J, Karppanen H, Kairaluoma M, Larmi T.
    Eur J Pharmacol; 1976 Aug; 38(2):275-9. PubMed ID: 182509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB, Wilkinson RG.
    Biochem Pharmacol; 1977 May 01; 26(9):887-9. PubMed ID: 193519
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA.
    Pharmacol Res Commun; 1977 Jan 01; 9(1):49-58. PubMed ID: 194263
    [No Abstract] [Full Text] [Related]

  • 14. An endogenous inhibitor protein of brain adenylate cyclase and cyclic nucleotide phosphodiesterase.
    Wallace RW, Lynch TJ, Tallant EA, Cheung WY.
    Arch Biochem Biophys; 1978 Apr 30; 187(2):328-34. PubMed ID: 208465
    [No Abstract] [Full Text] [Related]

  • 15. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A, Schultz J.
    Experientia; 1975 Aug 15; 31(8):883-4. PubMed ID: 169139
    [No Abstract] [Full Text] [Related]

  • 16. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
    Hunt NH, Evans T.
    Biochim Biophys Acta; 1980 Jun 13; 613(2):499-506. PubMed ID: 6256001
    [Abstract] [Full Text] [Related]

  • 17. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM, Cheng ZJ, Kuo SC.
    Eur J Pharmacol; 1995 Jun 23; 280(1):69-77. PubMed ID: 7498256
    [Abstract] [Full Text] [Related]

  • 18. Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase in rat cerebral cortex.
    Ye Y, O'Donnell JM.
    J Neurochem; 1996 May 23; 66(5):1894-902. PubMed ID: 8780016
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
    Reynolds CH, Claxton PT.
    Biochem Pharmacol; 1982 Feb 01; 31(3):419-21. PubMed ID: 6280730
    [Abstract] [Full Text] [Related]

  • 20. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents.
    Zhang B, Yang L, Konishi Y, Maeda N, Sakanaka M, Tanaka J.
    Neuropharmacology; 2002 Feb 01; 42(2):262-9. PubMed ID: 11804623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.